APA (7th ed.) Citation

Parra-Izquierdo, I., Melrose, A. R., Pang, J., Lakshmanan, H. H. S., Reitsma, S. E., Vavilapalli, S. H., . . . Aslan, J. E. (2022). Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function. Platelets, 33(3), 404. https://doi.org/10.1080/09537104.2021.1934665

Chicago Style (17th ed.) Citation

Parra-Izquierdo, Iván, et al. "Janus Kinase Inhibitors Ruxolitinib and Baricitinib Impair Glycoprotein-VI Mediated Platelet Function." Platelets 33, no. 3 (2022): 404. https://doi.org/10.1080/09537104.2021.1934665.

MLA (9th ed.) Citation

Parra-Izquierdo, Iván, et al. "Janus Kinase Inhibitors Ruxolitinib and Baricitinib Impair Glycoprotein-VI Mediated Platelet Function." Platelets, vol. 33, no. 3, 2022, p. 404, https://doi.org/10.1080/09537104.2021.1934665.